Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Edward S. Morris"'
Autor:
Chong Chyn Chua, Natasha S Anstee, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Rachel M Koldej, Stephen B Ting, Travis Perera, Amanda Johnston, John Reynolds, David Ritchie, Andrew H Wei
Publikováno v:
Blood. 140:3362-3364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::174c5ec8cd62af987d06caf65301346c
https://doi.org/10.1182/blood-2022-163084
https://doi.org/10.1182/blood-2022-163084
Autor:
Ashish Bajel, Travis Perera, Carolyn S. Grove, Stephen B. Ting, Edward S. Morris, Amanda Johnston, Chun-Kei-Kris Ma, Shuh Ying Tan, Natasha S Anstee, Julian Cooney, Chong Chyn Chua, Paula Marlton, Ashanka Beligaswatte, David Ritchie, Andrew H. Wei, John V. Reynolds, Devendra K Hiwase, Anoop K Enjeti
Publikováno v:
Blood. 138:368-368
Background: Adaptive resistance mechanisms leading to treatment failure have been identified in older patients receiving venetoclax (VEN) in combination with either azacitidine or low dose cytarabine (LDAC) as frontline therapy for acute myeloid leuk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a97f5cf2fe61ae593447d5130173675
https://doi.org/10.1182/blood-2021-149488
https://doi.org/10.1182/blood-2021-149488
Autor:
Noemi Horvath, John V. Reynolds, Tiffany Khong, Rose Turner, Krystal Bergin, Edward S. Morris, Ian Kerridge, Flora Yuen, Edwin Sze-Hung Lee, Sridurga Mithraprabhu, Shreerang Sridesai, Malgorzata Gorniak, Andrew Spencer, Anna Kalff, Hang Quach
Publikováno v:
Blood. 138:1663-1663
BACKGROUND Survival rates in multiple myeloma (MM) have significantly improved in recent decades with the advent of high-dose chemotherapy conditioned autologous stem cell transplantation (ASCT) and the availability of novel agents for induction ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de81c388711edf853c50109e5b1a40a1
https://doi.org/10.1182/blood-2021-152034
https://doi.org/10.1182/blood-2021-152034
Autor:
Yana A. Wilson, Renee J. Robb, Edward S. Morris, Kelli P. A. MacDonald, Heinrich Körner, Rachel D. Kuns, Allison R. Pettit, Vanessa Rowe, Tatjana Banovic, Kate A. Markey, Geoffrey R. Hill, Angela C. Burman, Stuart D. Olver, Neil C. Raffelt, Andrew D. Clouston, Christian R. Engwerda, Louise M. Randall, Alistair L. J. Don
Tumor necrosis factor (TNF) is a key cytokine in the effector phase of graft-versus-host disease (GVHD) after bone marrow transplantation, and TNF inhibitors have shown efficacy in clinical and experimental GVHD. TNF signals through the TNF receptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f499a9bbbef7635785cce421b8ea8cd
https://doi.org/10.1182/blood-2009-01-199927
https://doi.org/10.1182/blood-2009-01-199927
Autor:
Edward S. Morris, Flora Yuen, Edwin Sze-Hung Lee, Shreerang Sirdesai, Anna Kalff, Hang Quach, Tiffany Khong, Ian Kerridge, John V. Reynolds, Malgorzata Gorniak, Krystal Bergin, Sridurga Mithraprabhu, Andrew Spencer, Noemi Horvath
Publikováno v:
Blood. 132:3279-3279
Background Data from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (MRDR) shows that 85% of newly diagnosed multiple myeloma (NDMM) patients (pts) in ANZ are induced with bortezomib(V)-containing therapies, predominantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::883bfd5a5d3408a719dac96474389e01
https://doi.org/10.1182/blood-2018-99-113982
https://doi.org/10.1182/blood-2018-99-113982
Autor:
Mark J. Smyth, Rachel D. Kuns, Angela C. Burman, Vanessa Rowe, Steven A. Porcelli, Neil C. Raffelt, Geoffrey R. Hill, Edward S. Morris, Kelli P. A. MacDonald, Kate A. Markey, Helen M Morris, Alistair L. J. Don, Tatjana Banovic, Camile S. Farah, Gurdyal S. Besra, Andrew D. Clouston, Petr A. Illarionov
Publikováno v:
Blood. 113:5999-6010
Invariant natural killer T cells (iNKT cells) have pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects. iNKT cells are activated through their T-cell receptors by glycolipid moieties (typically the α-galactosylc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fef2b8e897f15fa392b19db34556cae
https://doi.org/10.1182/blood-2008-10-183335
https://doi.org/10.1182/blood-2008-10-183335
Autor:
Andrew D. Clouston, Helen M. Bofinger, Vanessa Rowe, Kelli P. A. MacDonald, Tatjana Banovic, Edward S. Morris, Alistair L. J. Don, R. Kuns, Geoffrey R. Hill, Angela C. Burman
Publikováno v:
Blood. 108:2485-2492
Host antigen-presenting cells (APCs) are known to be critical for the induction of graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT), but the relative contribution of specific APC subsets remains unclear. We have stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f765d53c9b44c6a4e2b69b7ebc7950b
https://doi.org/10.1182/blood-2006-04-016063
https://doi.org/10.1182/blood-2006-04-016063
Autor:
Anne Kelso, Michelle L. Janas, Norbert Kienzle, Stuart D. Olver, Kathy Buttigieg, Edward S. Morris, Penny Groves
Publikováno v:
Cancer Research. 66:571-580
An interleukin (IL)-4-containing tumor environment is reported to be beneficial for immune clearance of tumor cells in vivo; however, the effect of IL-4 on the effector CD8+ T cells contributing to tumor clearance is not well defined. We have used th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ab848337440067b4ed2579662ad588
https://doi.org/10.1158/0008-5472.can-05-1362
https://doi.org/10.1158/0008-5472.can-05-1362
Autor:
Steven A. Porcelli, Kelli P. A. MacDonald, Helen M. Bofinger, Rachel D. Kuns, Alistair L. J. Don, Dale I. Godfrey, Stuart D. Olver, Daniel G. Pellicci, Angela C. Burman, Vanessa Rowe, Norbert Kienzle, Tatjana Banovic, Geoffrey R. Hill, Mark J. Smyth, Edward S. Morris
Publikováno v:
Journal of Clinical Investigation. 115:3093-3103
NKT cells have pivotal roles in immune regulation and tumor immunosurveillance. We report that the G-CSF and FMS-like tyrosine kinase 3 ligand (Flt-3L) chimeric cytokine, progenipoietin-1, markedly expands the splenic and hepatic NKT cell population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcffd9103e96012db3cfe4d2edbeb77d
https://doi.org/10.1172/jci25249
https://doi.org/10.1172/jci25249
Autor:
Geoffrey R. Hill, Diana H. Johnson, James L.M. Ferrara, Vanessa Rowe, Edward S. Morris, Andrew D. Clouston, Kelli P. A. MacDonald, C. Filippich
Publikováno v:
Biology of Blood and Marrow Transplantation. 10:373-385
The use of granulocyte colony-stimulating factor (G-CSF)–mobilized peripheral blood as a source of stem cells has resulted in a high incidence of severe chronic graft-versus-host disease (cGVHD), which compromises the outcome of clinical allogeneic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66dde5a22a0da3713a42cfd89803ba4
https://doi.org/10.1016/j.bbmt.2004.02.002
https://doi.org/10.1016/j.bbmt.2004.02.002